alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
## Harcros Chemicals Inc. 5200 Speaker Road Kansas City, KS 66106 Telephone: 913/621-7747 Fax: 913/621-7746 E-mail: OrganicsCS@Harcros.com Date 10/11/12

Paul Campanella Document Control Office (DCO) (7407M) Office of Pollution Control and Toxics (OPPT) U.S. Environmental Protection Agency (EPA) EPA East Building, Room E6428 (202-564-8930) 1201 Constitution Ave., NW Washington, D.C. 20460 (202-564-8930) Attn: TSCA Section 4 40 CFR 

### § 799.5087 (Docket# EPA-HQ-OPPT-2007-0531) Telephone number: 202-564-8091 RE: Requestfor Extension ofTestingfor 0-Giuco-Heptonic acid, monosodium salt, (2 xi)- Dear Paul: Harcros Chemicals Inc. submitted a letter ofintentfor D-gluco-Heptonic acid, monosodium salt, (2.xi.)- [CAS# 31138-65-5] on April 5, 2011. We are requesting an extension until May 31, 2013 to complete the testing requirements in accordance with EPA'sfinal rule, Testing ofCertain High Production Volume Chemicals; Second Group ofChemicals, published in the Federal Register on January 7, 2011 at 76 Fed. Reg. 1067. D-gluco-Heptonic acid, monosodium salt, (2.xi.)- [CAS# 31138-65-5] contains water as a result ofthe manufacturing process. It was necessary for Harlan Laboratories, ourtesting facility, to determine the amount ofwater contained in the sample Harcros provided for testing purposes. Harlan Laboratories experienced difficulty removing the water as they were unableto obtain a constant weight during the drying process. After discussions with EPA, Harcros was ableto obtain advice on howto resolve this issue. However, this has caused a substantial delay which has changed the expected completion dateto April of 2013. Please let us know ifthis extension request is acceptable to EPA. Ifany further information is required, please do not hesitate to contact me at (913) 621-7802 or at asavini@harcros.com.

Ann Marie Savini Harcros Chemicals Inc. Regulatory Specialist
cc: Peter Radford Howard Stevenson John Miles James Grantham Don Meuschke File 

### 1111111111111111111111111111111111111111111111111111111111111111 4 0 1 3 0 0 0 0 0 0 2



# CONTAINS NO CE'ORIGIN ID: KCKA <913) 621-7733 JAKE BOOREM HARCROS CHEMICALS INC 5200 SPEAKER RD KANSAS CITY, KS 66106 UNITED STATES US SHIP DATE: 110CT12 ACTWGT: 0.5 LB MAN CAD: 09784151CAFE2511 BILL THIRD PARTY 10

# OPPT DOC CONTROL OFFICE EPA EAST

., 

# "'**~** 

## If**~ ~**  

## iii 

# 1201 CONSTITUTION AVE NW TSCA SECTION 4 

# WASHINGTON DC 20460 (202) 664- 8930 

## REF: POSTAGE

j I 'I

....'IIYI

# Pll'~~ Wlolo/JI

..

### II~**~~~~~~"~~Nrl;** Express 

# [E)!**~**

# 5408 5998 8037 FRI - 12OCT A1 PRIORITYOVERNIGHT 

# XC RDVA 20460 DC-US 

# DCA
DRAFT

ID

Simple or

Special Name Type Description Error Message 

121 SPECIAL

Restricted Use of USSGL Account 421100 Compound

The use of USSGL account 421100 is restricted to specific Department of Defense TAS only. This TAS is not permitted to report USS

U.S. Standard General Ledger

Data Validations - Summary

Part 2SUPPLEMENT

Bulletin No. 2021-17 DRAFT VII VSR - 1
Schedule B (Form 941):

(Rev. March 2024)

Report of Tax Liability for Semiweekly Schedule Depositors

Department of the Treasury — Internal Revenue Service

960311

OMB No. 1545-0029

 

Employer identification number 

(EIN) —

Name (not your trade name)

Calendar year (Also check quarter)

Report for this Quarter... 

(Check one.)

1: January, February, March

2: April, May, June

3: July, August, September

4: October, November, December

Use this schedule to show your TAX LIABILITY for the quarter; don’t use it to show your deposits. When you file this schedule with Form 941, 

don’t change your tax liability by adjustments reported on any Forms 941-X or 944-X. You must fill out this schedule and attach it to Form 941 

if you’re a semiweekly schedule depositor or became one because your accumulated tax liability on any day was $100,000 or more. Write 

your daily tax liability on the numbered space that corresponds to the date wages were paid. See Section 11 in Pub. 15 for details.

Month 1

1 .

2 .

3 .

4 .

5 .

6 .

7 .

8 .

9 .

10 .

11 .

12 .

13 .

14 .

15 .

16 .

17 .

18 .

19 .

20 .

21 .

22 .

23 .

24 .

25 .

26 .

27 .

28 .

29 .

30 .

31 .

Tax liability for Month 1

.

Month 2

1 .

2 .

3 .

4 .

5 .

6 .

7 .

8 .

9 .

10 .

11 .

12 .

13 .

14 .

15 .

16 .

17 .

18 .

19 .

20 .

21 .

22 .

23 .

24 .

25 .

26 .

27 .

28 .

29 .

30 .

31 .

Tax liability for Month 2

.

Month 3

1 .

2 .

3 .

4 .

5 .

6 .

7 .

8 .

9 .

10 .

11 .

12 .

13 .

14 .

15 .

16 .

17 .

18 .

19 .

20 .

21 .

22 .

23 .

24 .

25 .

26 .

27 .

28 .

29 .

30 .

31 .

Tax liability for Month 3

.

Fill in your total liability for the quarter (Month 1 + Month 2 + Month 3). 

Total must equal line 12 on Form 941. 

Total liability for the quarter

. For Paperwork Reduction Act Notice, 

see separate instructions.

www.irs.gov/Form941 Cat. No. 11967Q Schedule B (Form 941) (Rev. 3-2024)
IN THE UNITED STATES DISTRICT COURT

FOR THE EASTERN DISTRICT OF PENNSYLVANIA

LEE ARTERS t/a GREENDALE BUILDERS

C.A. 02-4388

District Court Docket Number

vs.

ZURICH AMERICAN INSURANCE ET AL

Notice of Appeal Filed 12/18/03

Court Reporter(s)/ESR Operator(s)

Filing Fee:

 Notice of Appeal X Paid Not Paid Seaman

 Docket Fee X Paid Not Paid USA/VI

CJA Appointment (Attach Copy of Order)

 Private Attorney

 Defender Association or Federal Public Defender

 Motion Pending

Leave to Proceed In Forma Pauperis status, if applicable: (Attach copy of the Order)

 Motion Granted

 Motion Denied

 Motion pending before district judge

Certificate of probable cause (state habeas corpus): (Attach copy of the Order)

 Granted

 Denied

 Pending

 Defendant's Address (for criminal appeals)

 

 Prepared by : 

Mrs. Norman

Deputy Clerk Signature/Date

PLEASE APPEND TO THE NOTICE OF APPEAL AND FORWARD TO

THE OFFICE OF THE CLERK, U.S. COURT OF APPEALS

notapp.frm

Case 2:02-cv-04388-JF Document 28 Filed 12/18/2003 Page 1 of 1
# Sheet1

&"Arial,Bold"Part 2SUPPLEMENT	&"Arial,Bold"DRAFT	&"Arial,Bold"Fiscal Year 2017 ReportingSection VII

&"Arial,Bold"Bulletin No. 2016-05	&"Arial,Bold"DRAFT VII VSR - &P	&"Arial,Bold"IRC Handout 4/21/16
No. 65433.

#### Cresca Co., Inc., et al. *v.*United States,

protests 60/20657, etc. (New York).

Opinion by

Donlon, J.

In accordance with stipulation of counsel that the merchandise consists of bread similar in all material respects to that the subject of *United States*v. *Nordic Baking & Importing Co., Inc.*(47 C.C.P.A. 78, C.A.D. 733), the claim of the plaintiffs was sustained.
Exhibit
32.1
 
 
 CERTIFICATION
PURSUANT TO
 18
U.S.C. SECTION 1350,
 AS
ADOPTED PURSUANT TO
 SECTION
906 OF THE
 SARBANES-OXLEY
ACT OF 2002
 
 
 In
connection with the Annual Report of EnerTeck Corporation (the “Company”) on
Form 10-K for the period ended December 31, 2008, as filed with the Securities
and Exchange Commission (the “Report”), the undersigned certifies, pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, to the best of the undersigned’s knowledge, that:
 
 (1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
 
 (2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
 
 
 Dated:  March 30,
      2009
              By:
              /s/ Dwaine
      ReeseDwaine
      Reese,Chief
      Executive Officer and Chairman ofthe
      Board (Principal Executive Officer)Dated:  March 30,
      2009
              By:
              /s/ Richard
      DicksRichard
      Dicks, Chief Financial Officer(Principal
      Financial Officer)
United States Court of Appeals

for the Fifth Circuit

No. 21-40031

Summary Calendar

United States of America, 

Plaintiff—Appellee,

versus

Jose Alberto Meza,

Defendant—Appellant.

Appeal from the United States District Court

for the Eastern District of Texas

USDC No. 4:98-CR-47-11

Before Higginbotham, Higginson, and Duncan, Circuit Judges.

Per Curiam:*

Jose Alberto Meza, federal prisoner # 07094-078, appeals the denial 

of his 18 U.S.C. § 3582(c)(1)(A)(i) motion for compassionate release. The 

district court denied relief based upon Meza’s failure to show that 

extraordinary and compelling reasons warranted relief, and we review that 

* Pursuant to 5th Circuit Rule 47.5, the court has determined that this 

opinion should not be published and is not precedent except under the limited 

circumstances set forth in 5th Circuit Rule 47.5.4.

United States Court of Appeals

Fifth Circuit

FILED

June 15, 2022

Lyle W. Cayce

Clerk

Case: 21-40031 Document: 00516357745 Page: 1 Date Filed: 06/15/2022
No. 21-40031

2

denial for an abuse of discretion. See United States v. Chambliss, 948 F.3d 691, 

693 (5th Cir. 2020).

Despite that Meza suffers from hypertension, diabetes, high 

cholesterol, and severe obesity, the district court permissibly denied relief on 

the grounds that these conditions were sufficiently managed, Meza was fully 

vaccinated, and he was housed in a facility with no active COVID-19 

infections among inmates. See United States v. Rodriguez, 27 F.4th 1097, 

1100-01 (5th Cir. 2022); United States v. Thompson, 984 F.3d 431, 433-35 (5th 

Cir.), cert. denied, 141 S. Ct. 2688 (2021). Meza’s assertions challenging the 

district court’s reasoning and the Government’s arguments on appeal are 

insufficiently briefed to warrant consideration. See United States v. Scroggins, 

599 F.3d 433, 446-47 (5th Cir. 2010); Yohey v. Collins, 985 F.2d 222, 224-25 

(5th Cir. 1993). To the extent that Meza seeks to incorporate by reference 

arguments that he previously made in his district-court pleadings, he may not 

do so. See United States v. Abdo, 733 F.3d 562, 568 (5th Cir. 2013). Given its 

determination that Meza failed to show extraordinary and compelling 

reasons, the district court was not required to consider the 18 U.S.C. 

§ 3553(a) factors. See Rodriguez, 27 F.4th at 1099-1101; Thompson, 984 F.3d 

at 433-35.

AFFIRMED.

Case: 21-40031 Document: 00516357745 Page: 2 Date Filed: 06/15/2022
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Federal Financial Institutions Examination Council

          - [Docket No. AS23-18]

# AGENCY:

Appraisal Subcommittee of the Federal Financial Institutions Examination Council.

# ACTION:

Notice of Special Closed Meeting.

# SUPPLEMENTARY INFORMATION:

In accordance with Section 1104(b) of Title XI of the Financial Institutions Reform, Recovery, and Enforcement Act of 1989, as amended, notice is hereby given that the Appraisal Subcommittee (ASC) met for a Special Closed Meeting on this date.

*Location:*                     Virtual meeting via Webex.                

*Date:*                     November 8, 2023.                

*Time:*                     11:15 a.m. ET.                

*Action and Discussion Item:*                     Personnel Matter.                

The ASC convened a Special Closed Meeting to discuss a personnel matter. No action was taken by the ASC.

James R. Park,

Executive Director.

[FR Doc. 2023-25283 Filed 11-15-23; 8:45 am]

BILLING CODE 6700-01-P
----

----

I Communications

Commission

----

Taux de change de l'euro (1)

20 juillet 2006

(2006/C 169/01)

1 euro= 

----

(1)

Source: taux de change de référence publié par la Banque centrale européenne.

----

----

JOURS FÉRIÉS POUR L'ANNÉE 2007

(2006/C 169/02)

LUXEMBOURG: mêmes jours qu'à Bruxelles.

Le travail reprendra normalement le jeudi 3 janvier 2008.

Sans préjuger le calendrier des jours fériés de 2008, le mercredi 2 janvier 2008 sera considéré jour férié au titre de cette année-là.

La Commission se réserve le droit de modifier ces dispositions si les nécessités de service l'exigent.

----

----

JOURS FÉRIÉS POUR L'ANNÉE 2008

(2006/C 169/03)

LUXEMBOURG: mêmes jours qu'à Bruxelles, sauf le lundi 21 juillet étant remplacé par le lundi 23 juin, fête nationale du Luxembourg.

Le travail reprendra normalement le lundi 5 janvier 2009.

Sans préjuger le calendrier des jours fériés de 2009, le jeudi 1er janvier 2009 et le vendredi 2 janvier 2009 seront considérés jours fériés au titre de cette année-là.

La Commission se réserve le droit de modifier ces dispositions si les nécessités de service l'exigent.

----

----

Notification préalable d'une opération de concentration

(Affaire COMP/M.4266 — Atel Energia/Azienda Energetica — Etschwerke/ Energ.IT)

Cas susceptible d'être traité selon la procédure simplifiée

(2006/C 169/04)

(Texte présentant de l'intérêt pour l'EEE)

----

(1)JO L 24 du 29.1.2004, p. 1.

(2)JO C 56 du 5.3.2005, p. 32.

----
<PAGE>
<TABLE>
                                                                                               EXHIBIT 12
                                  INDIANA MICHIGAN POWER COMPANY
                  Computation of Consolidated Ratio of Earnings to Fixed Charges
                                 (in thousands except ratio data)
<CAPTION>
                                                                     Year Ended December 31,             
                                                       1992       1993       1994       1995       1996  
<S>                                                  <C>        <C>        <C>        <C>        <C>     
Fixed Charges:                                                                                           
  Interest on First Mortgage Bonds. . . . . . . .    $ 56,965   $ 53,771   $ 43,564   $ 43,410   $ 41,209
  Interest on Other Long-term Debt. . . . . . . .      26,330     23,504     24,725     23,564     20,100
  Interest on Short-term Debt . . . . . . . . . .       1,614      1,085      1,883      2,003      2,982
  Miscellaneous Interest Charges. . . . . . . . .       2,866      3,039      3,520      3,472      3,262
  Estimated Interest Element in Lease Rentals . .      84,800     84,300     85,000     82,700     82,600
       Total Fixed Charges. . . . . . . . . . . .    $172,575   $165,699   $158,692   $155,149   $150,153

Earnings:
  Net Income. . . . . . . . . . . . . . . . . . .    $123,983   $129,344   $157,502   $141,092   $157,153
  Plus Federal Income Taxes . . . . . . . . . . .      28,191     38,826     32,303     55,990     76,899
  Plus State Income Taxes . . . . . . . . . . . .       1,547      7,492      6,063      7,058      9,270
  Plus Fixed Charges (as above) . . . . . . . . .     172,575    165,699    158,692    155,149    150,153
       Total Earnings . . . . . . . . . . . . . .    $326,296   $341,361   $354,560   $359,289   $393,475
                                                                                                         
Ratio of Earnings to Fixed Charges. . . . . . . .        1.89       2.06       2.23       2.31       2.62
</TABLE>
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<CIK>          0001052971
<NAME>         IHLLC
<MULTIPLIER>   1,000
<CURRENCY>     US$

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               MAR-31-2000
<EXCHANGE-RATE>                                      1
<CASH>                                          51,818
<SECURITIES>                                         0
<RECEIVABLES>                                   67,569
<ALLOWANCES>                                         0
<INVENTORY>                                    260,850
<CURRENT-ASSETS>                               384,638
<PP&E>                                          81,358
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 832,417
<CURRENT-LIABILITIES>                          476,514
<BONDS>                                        200,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                      21,027
<TOTAL-LIABILITY-AND-EQUITY>                   832,417
<SALES>                                        266,894
<TOTAL-REVENUES>                               266,894
<CGS>                                          215,056
<TOTAL-COSTS>                                  260,896
<OTHER-EXPENSES>                               (1,081)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               8,110
<INCOME-PRETAX>                                  (185)
<INCOME-TAX>                                       575
<INCOME-CONTINUING>                              (729)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (729)
<EPS-BASIC>                                          0
<EPS-DILUTED>                                        0


</TABLE>
EXHIBIT
32.2




CERTIFICATION
PURSUANT TO 18 USC, SECTION 1350,


AS
ADOPTED PURSUANT TO SECTION 906


OF
THE SARBANES-OXLEY ACT OF 2002





In
connection with the Annual Report of Bio Solutions Manufacturing, Inc. (the
“Company”) on Form 10-K for the year ended October 31, 2009, as filed with the
Securities and Exchange Commission on or about the date hereof (the “Report”),
I, Patricia Spreitzer, Chief Financial Officer of the Company, certify, pursuant
to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley
Act of 2002, that:





(1)
   The Report fully complies with the requirements of Sections 13(a)
or 15(d) of the Securities Exchange Act of 1934; and





(2)
   Information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.





Dated:
      March 5, 2010
              /s/ Patricia
  SpreitzerBy:
      Patricia SpreitzerIts:
      Chief Financial Officer, Secretary, and Treasurer
                (Principal Financial and Accounting
      Officer)





A signed
original of this written statement required by Section 906 has been provided to
Bio Solutions Manufacturing, Inc. and will be retained by Pollex, Inc. and
furnished to the Securities and Exchange Commission or its staff upon
request.
# C_2017038EN.01001702.xml

| 6.2.2017 | EN | Official Journal of the European Union | C 38/17 |
| --- | --- | --- | --- |

6.2.2017

EN

Official Journal of the European Union

C 38/17

---

Appeal brought on 25 November 2016 by the European Commission against the judgment of the General Court (Eighth Chamber) of 15 September 2016 in Case T-219/13, Ferracci v Commission

(Case C-624/16 P)

(2017/C 038/23)

Language of the case: Italian

Parties

Parties

Appellant: European Commission (represented by: P. Stancanelli, D. Grespan, F. Tomat, acting as agents)

Appellant:

Other parties to the proceedings: Pietro Ferracci, Italian Republic

Other parties to the proceedings:

Form of order sought

Form of order sought

The appellant claims that the Court should:

| — | set aside the judgment under appeal to the extent that it declares the proceedings at first instance admissible for the purpose of the final limb of the fourth paragraph of Article 263 TFEU; |
| --- | --- |

—

set aside the judgment under appeal to the extent that it declares the proceedings at first instance admissible for the purpose of the final limb of the fourth paragraph of Article 263 TFEU;

| — | declare the action at first instance inadmissible under the second and last limb of the fourth paragraph of Article 263 TFEU and consequently dismiss it in its entirety; |
| --- | --- |

—

declare the action at first instance inadmissible under the second and last limb of the fourth paragraph of Article 263 TFEU and consequently dismiss it in its entirety;

| — | order Mr Ferracci to pay the costs incurred by the Commission in the proceedings before the General Court and in the present proceedings. |
| --- | --- |

—

order Mr Ferracci to pay the costs incurred by the Commission in the proceedings before the General Court and in the present proceedings.

Pleas in law and main arguments

Pleas in law and main arguments

By a single plea in law, divided into three parts, the Commission claims that the last limb of the fourth paragraph of Article 263 TFEU was misinterpreted and misapplied in that the General Court ruled that the action of the applicant at first instance was admissible on the basis of that provision. In particular, the General Court erred in law by finding that the contested act amounted to a regulatory act which was of direct concern to the applicant at first instance and did not entail implementing measures in respect of the applicant himself.

---
IN THE UNITED STATES DISTRICT COURT

FOR THE EASTERN DISTRICT OF PENNSYLVANIA

SHEET METAL WORKERS :

LOCAL 441 HEALTH & WELFARE :

PLAN, et al., : CIVIL ACTION

Plaintiffs :

:

v. : NO. 04-5898

:

GLAXOSMITHKLINE, PLC, et al, :

Defendants :

:

O R D E R

STENGEL, J.

AND NOW, this 2nd day of November, 2009, upon careful consideration of the

defendants' motion for judgment on the pleadings (Document #221) and the plaintiffs' response

thereto, IT IS HEREBY ORDERED that:

1. The defendants' motion for judgment on the pleadings is GRANTED with respect

to all antitrust and consumer protection claims in Counts I and II of the Amended

Consolidated Complaint. These claims are dismissed without prejudice.

2. The defendants' motion for judgment on the pleadings is DENIED with respect to

the unjust enrichment claims arising under Alabama and Illinois law; it is

GRANTED with respect to all other unjust enrichment claims in Count III of the

Amended Consolidated Complaint, and these claims are dismissed without

prejudice.

3. Plaintiff Sidney Hillman is dismissed from this action.

4. Plaintiffs are granted 30 days leave to amend their complaint to enumerate the

states into which reimbursements were sent during the relevant period.

BY THE COURT:

/s/ Lawrence F. Stengel 

LAWRENCE F. STENGEL, J.

Case 2:04-cv-05898-LS Document 234 Filed 11/03/09 Page 1 of 1
No. 60773.

#### Sandoz Chemical Works, Inc. *v.*United States,

protest 267228-K (New York).

Opinion by

Wilson, J.

In accordance with stipulation of counsel that the merchandise consists of Skimpex, which product is not obtained from any oil, fat, or fatty acid described in the Internal Revenue Code, but is derived in part. *507from sperm oil, which is not covered by the statute, the claim of the plaintiff was sustained.